Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression.

Saved in:
Bibliographic Details
Title: Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression.
Authors: Agrawal, Deepti1, Cisarova, Katarina2 katarina.vizar-cisarova@medunigraz.at, Vosberg, Sebastian2,3,4,5, Allmendinger, Fabian6,7,8,9, Munkhbaatar, Enkhtsetseg1,10, Dandachi, Nadia2, Fernandez Hernandez, Francisco Jose2, Tonietto, Marta2,11, Jäger, Vanessa2, Anton, Martina12, Keller, Eva C.1,13, Jesinghaus, Moritz12,14, Meinhardt, Anna-Lena1, Haefner, Verena15, Stoeger, Tobias15, Steiger, Katja12,16, McGranahan, Nicholas17,18, Dengler, Michael A.2, Wahida, Adam1,19, Jost, Philipp J.1,2,20,21 philipp.jost@medunigraz.at
Source: Science Advances. 1/23/2026, Vol. 12 Issue 4, p1-13. 13p.
Database: Academic Search Ultimate
Description
ISSN:23752548
DOI:10.1126/sciadv.adz9227